Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Concerta methylphenidate: Phase III data; NDA under review

In a U.S. Phase III crossover trial of once daily Concerta in 64 children with ADHD, significant improvement in inattention and overactivity score

Read the full 234 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE